Second Vice Minister of Health and Welfare Park Min-soo promised the National Assembly that he would make a rule that gives preferential prices to medicines made by innovative pharmaceutical companies over other medicines. This is in the same context as Vice Minister Park Min-soo clearly expressed his will to improve the drug pricing system, which includes specific drug price preferential treatment for innovative new drugs and essential drugs, at a meeting of the Ministry of Health and Welfare's press conference in February. Last month, at the Health and Welfare Committee of the National Assembly, Vice Minister Park asked that the preferential treatment policy for innovative drugs be made clear so that the mandatory